ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NXGL NexGel Inc

2.73
0.06 (2.25%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
NexGel Inc NXGL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 2.25% 2.73 16:30:00
Open Price Low Price High Price Close Price Prev Close
2.65 2.65 2.79 2.73 2.67
more quote information »

Recent News

Date Time Source Heading
3/27/202409:00GLOBENEXGEL Reschedules Fourth Quarter and Full Year 2023..
3/21/202409:00GLOBENEXGEL to Report Fourth Quarter and Full Year 2023 Financial..
3/05/202409:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202409:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202409:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202408:30GLOBENEXGEL to Present at the iAccess Alpha Best Ideas Spring..
2/21/202416:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/21/202416:15EDGAR2Form 8-K - Current report
2/21/202416:05GLOBENEXGEL Announces $975,000 Registered Direct Offering Led by..
1/31/202409:05EDGAR2Form 8-K - Current report
1/18/202409:00GLOBENEXGEL to Present at The Microcap Conference, January 30th..
1/16/202416:30EDGAR2Form 8-K - Current report
1/09/202408:30GLOBENEXGEL Subsidiary, CG Converting and Packaging, Begins..
12/29/202316:30EDGAR2Form 8-K - Current report
12/26/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202316:52EDGAR2Form 8-K - Current report
12/11/202308:15EDGAR2Form 8-K - Current report
12/11/202308:00GLOBENEXGEL Announces Partnership with STADA to Distribute and..
12/05/202308:10EDGAR2Form 8-K - Current report
12/05/202308:00GLOBENEXGEL Acquires Kenkoderm Psoriasis Skincare Line
11/13/202317:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202317:10EDGAR2Form 8-K - Current report
11/13/202316:05GLOBENEXGEL Reports Record Third Quarter 2023 Revenue of $1.2..
11/02/202309:00GLOBENEXGEL to Report Third Quarter 2023 Financial Results on..
10/30/202308:30EDGAR2Form 8-K - Current report
10/30/202308:00GLOBENEXGEL Secures Supply Agreement with AbbVie
9/26/202309:49GLOBENEXGEL to Participate in the LD Micro Main Event XVI on..
9/14/202318:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/23/202318:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/21/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/21/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/21/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202317:29EDGAR2Form 8-K - Current report
8/14/202316:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202316:05GLOBENEXGEL Reports Second Quarter 2023 Record Revenue of $1.17..
8/02/202309:00GLOBENEXGEL to Report Second Quarter 2023 Financial Results on..
7/19/202309:10GLOBENEXGEL Partners with Enigma Health to Distribute its Leading..
6/15/202309:00GLOBENEXGEL to Participate in Maxim Group’s Virtual Healthcare..
5/24/202309:00GLOBENEXGEL to Participate in the LD Micro Invitational XIII on..
5/15/202316:05GLOBENEXGEL Reports First Quarter 2023 Financial Results
5/09/202309:15GLOBENEXGEL to Report First Quarter 2023 Financial Results on May..

Your Recent History

Delayed Upgrade Clock